Biochemical and Molecular Genetic Characterization of G6PD Deficiency in Newborn, Benin

dc.contributor.authorAkpovi, D. Casimir
dc.contributor.authorFiogbe, E.M Salomon
dc.contributor.authorSegbo, A.G. Julien
dc.date.accessioned2026-06-02T16:06:57Z
dc.date.available2026-06-02T16:06:57Z
dc.date.issued2019
dc.description.abstractBackground: In Benin, the diagnosis of G6PD deficiency is based on the biochemical test performed by the quantitative spectrophotometry assay of the enzymatic activity. We used the results of the molecular gene test to verify the reliability of the biochemical diagnostic test. The distribution of genes polymorphism associated with the G6PD deficiency in neonates is also determined throughout the country. Material and Methods: This is a crosssectional descriptive study carried on with 178 neonates aged ≤7 days. Blood samples were screened for quantitative G6PD enzymatic activity using Cypress Diagnostics kit (Cypress Diagnostics, Belgium). G6PD genotype analysis was performed using specific primers for PCR amplification of G6PD gene containing the common African mutations A376G, G202A, A542T, and T968C. We used Chi-2 test to compare the means of qualitative data and Student’s t-test to ascertain difference between group’s characteristics. A p-value of <0.05 was deemed significant. Results: The mean value of normal G6PD activity was 16.25 U/g Hb. Enzyme activity was significantly lower in female newborns of genotype A-(376/202) /A-(376/202) (p<0.01) and in males genotype A-(376/202) (p<0.001). The probability of being deficient when the test of enzymatic activity is positive among the true deficit (Se) was 0.42. The probability of being non-deficient when the test is negative among the non-deficient (Sp) was 0.89, that of being deficient when the test is positive (PPV) was 0.52 and the probability of being non-negative when the test is negative (VPN) was 0.85. Genotypes B/B, A/B, A/A, A-(376/202)/B, A-(376/202)/A, A-(376/202)/A-(376/202) were identified in female newborns with respective proportion of 39.56%, 13.19%, 7.69%, 24.18%, 13.19% and 2.20%. In males, 64.37% were genotype B, 9.20% genotype A and 26.44% genotype A-(376/202). The northern departments had the highest frequencies of G6PD A-(376/202) (33.18% to 37.73%) while the lowest levels were seen in the south (25.58% to 28.62%). Conclusion: Enzymatic activity showed good diagnostic value in male subjects but not in heterozygous female. The highest frequency of G6PD A-(376/202) mutation was in the North Benin.
dc.identifier.doi10.12691/ajbr-7-2-2
dc.identifier.otherBECDB-9945
dc.identifier.urihttps://dspace.uac.bj/handle/123456789/8853
dc.language.isofr
dc.relation.ispartofAmerican Journal of Biomedical Research
dc.subjectG6PD deficiency
dc.subjectenzymatic activity
dc.subjectDNA test
dc.subjectneonate
dc.subjectBenin
dc.titleBiochemical and Molecular Genetic Characterization of G6PD Deficiency in Newborn, Benin
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
913fa88468435de94f770995f29060fa.pdf
Size:
189.97 KB
Format:
Adobe Portable Document Format

Collections